New pill aims to ease aching knees in major trial
NCT ID NCT07203547
Summary
This study aims to see if a new tablet called Laybon is as good as an existing tablet called Layla at reducing knee pain from osteoarthritis. About 172 adults with knee osteoarthritis will take one of the tablets for 8 weeks. The main goal is to measure changes in knee pain during daily activities.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.